CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
Episodes 106-120 of 739
Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
MinuteCE®Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
MinuteCE®Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
Potassium Binders in Practice: Clinical Trial Evidence
MinuteCE®Potassium Binders in Practice: Clinical Trial Evidence
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
MinuteCE®Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
MinuteCE®Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
- advertisement
Future Directions in Managing Hyperkalemia in CKD and HF
MinuteCE®Future Directions in Managing Hyperkalemia in CKD and HF
Current FSGS Treatment Landscape: More Questions Than Answers
MinuteCE®Current FSGS Treatment Landscape: More Questions Than Answers
FSGS: Interpretation of Proteinuria Reduction Thresholds
MinuteCE®FSGS: Interpretation of Proteinuria Reduction Thresholds
Emerging Therapies in Managing Adult and Pediatric Patients With FSGS: Latest Data
MinuteCE®Emerging Therapies in Managing Adult and Pediatric Patients With FSGS: Latest Data
- advertisement
Monitoring FSGS: Traditional and Novel Biomarkers
MinuteCE®Monitoring FSGS: Traditional and Novel Biomarkers
DEARA Versus SOC in FSGS Management: Clinical Trial Insights
MinuteCE®DEARA Versus SOC in FSGS Management: Clinical Trial Insights
Treatment Considerations for Pediatric Patients With FSGS
MinuteCE®Treatment Considerations for Pediatric Patients With FSGS











































